{"log_id": 9111151783639749902, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0.05519, "average": 0.837935, "min": 0.360852}, "location": {"width": 204, "top": 91, "height": 34, "left": 880}, "words": "说明第5/6页"}, {"probability": {"variance": 0.001871, "average": 0.981623, "min": 0.827021}, "location": {"width": 943, "top": 150, "height": 71, "left": 144}, "words": "步骤进行进一步的纯化。随后,添加变性缓冲液(6M氯化胍盐,20mM"}, {"probability": {"variance": 0.000847, "average": 0.98602, "min": 0.881473}, "location": {"width": 844, "top": 198, "height": 74, "left": 159}, "words": "ris/HC1,pH8.0)并于室温振荡2小时对纯化的包涵体进行消化"}, {"probability": {"variance": 0.000584, "average": 0.9936, "min": 0.866668}, "location": {"width": 872, "top": 246, "height": 68, "left": 215}, "words": "为了分离Ig反应活性的折叠形式,该变性批次被转入透析管(消化"}, {"probability": {"variance": 0.006855, "average": 0.974529, "min": 0.547494}, "location": {"width": 948, "top": 294, "height": 71, "left": 146}, "words": "限度12-14KDa)并于室温对100倍体积的半胱氨酸溶液(5mM半胱氨酸)"}, {"probability": {"variance": 0.000261, "average": 0.994398, "min": 0.917218}, "location": {"width": 727, "top": 349, "height": 66, "left": 144}, "words": "搅动透析12小时。然后再对蒸馏水透析以除去半胱氨酸"}, {"probability": {"variance": 0.003844, "average": 0.981032, "min": 0.672095}, "location": {"width": 875, "top": 390, "height": 70, "left": 215}, "words": "为获得具有减弱IgE反应活性的构象,第一次要对20mM醋酸钠缓冲"}, {"probability": {"variance": 6.8e-05, "average": 0.996032, "min": 0.95839}, "location": {"width": 911, "top": 440, "height": 70, "left": 146}, "words": "液(pH5.0)透析。然后再对蒸馏水进行透析。在去除以后,通过离心"}, {"probability": {"variance": 2e-06, "average": 0.999292, "min": 0.994242}, "location": {"width": 944, "top": 487, "height": 71, "left": 148}, "words": "该水溶的过敏原从沉淀的聚集物中分离出来。该上清含有所要的可溶性重"}, {"probability": {"variance": 0.0003, "average": 0.994571, "min": 0.902421}, "location": {"width": 947, "top": 535, "height": 71, "left": 148}, "words": "组过敏原。也可以使用其它的缓冲能力从3.5到6.5,优选从4.0到5.5"}, {"probability": {"variance": 0.000396, "average": 0.995672, "min": 0.885223}, "location": {"width": 944, "top": 585, "height": 69, "left": 149}, "words": "的酸性缓冲液代替醋酸钠缓冲液。这种类型的缓冲系统的例子在文献中有"}, {"probability": {"variance": 1e-06, "average": 0.998624, "min": 0.997199}, "location": {"width": 147, "top": 664, "height": 35, "left": 152}, "words": "充分的描述"}, {"probability": {"variance": 0, "average": 0.999641, "min": 0.997553}, "location": {"width": 879, "top": 678, "height": 68, "left": 219}, "words": "用两种方法产生的沉淀下来的重组过敏原可按同样的方案进行再变"}, {"probability": {"variance": 0.000305, "average": 0.994961, "min": 0.931969}, "location": {"width": 420, "top": 745, "height": 49, "left": 150}, "words": "性及处理。这可明显地增加产量"}, {"probability": {"variance": 7.5e-05, "average": 0.997621, "min": 0.9508}, "location": {"width": 880, "top": 772, "height": 67, "left": 220}, "words": "在透析步骤之后,产物纯度约为95%。此基本的昆虫毒性过敏原进一"}, {"probability": {"variance": 0.007271, "average": 0.972202, "min": 0.587404}, "location": {"width": 949, "top": 820, "height": 70, "left": 152}, "words": "步的纯化步骤是用例如 Source S( Pharmacia, Freiburg,德国)的阳离"}, {"probability": {"variance": 0.008415, "average": 0.975245, "min": 0.487294}, "location": {"width": 953, "top": 866, "height": 72, "left": 152}, "words": "子交换层析(缓冲液pH7.2)和凝胶过滤一除去极少的高分子量和低"}, {"probability": {"variance": 0.005409, "average": 0.902411, "min": 0.828867}, "location": {"width": 95, "top": 900, "height": 45, "left": 699}, "words": "药经"}, {"probability": {"variance": 1e-06, "average": 0.99959, "min": 0.996717}, "location": {"width": 564, "top": 929, "height": 56, "left": 152}, "words": "分子量的杂质以外,凝胶过滤也用来进"}, {"probability": {"variance": 0.012253, "average": 0.974484, "min": 0.422797}, "location": {"width": 860, "top": 958, "height": 74, "left": 222}, "words": "基于下面的特性对产品的质量进控制其以5概括于下表:"}, {"probability": {"variance": 0.036548, "average": 0.919316, "min": 0.386187}, "location": {"width": 246, "top": 1033, "height": 36, "left": 223}, "words": "n-抗原天然抗原"}, {"probability": {"variance": 0.000667, "average": 0.981159, "min": 0.896549}, "location": {"width": 450, "top": 1054, "height": 54, "left": 644}, "words": "具有然IgE反应具有减弱IgE反"}, {"probability": {"variance": 0, "average": 0.99978, "min": 0.999603}, "location": {"width": 60, "top": 1113, "height": 31, "left": 177}, "words": "特性"}, {"probability": {"variance": 0.02846, "average": 0.900482, "min": 0.608317}, "location": {"width": 139, "top": 1119, "height": 30, "left": 645}, "words": "活性的训"}, {"probability": {"variance": 1e-06, "average": 0.999217, "min": 0.99766}, "location": {"width": 168, "top": 1107, "height": 33, "left": 905}, "words": "应活性的折叠"}, {"probability": {"variance": 0.003659, "average": 0.97238, "min": 0.791624}, "location": {"width": 448, "top": 1171, "height": 48, "left": 179}, "words": "SDS-PAGB(非还原条件)中的表观分"}, {"probability": {"variance": 0, "average": 0.946765, "min": 0.946765}, "location": {"width": 68, "top": 1196, "height": 23, "left": 649}, "words": " 25kda"}, {"probability": {"variance": 0.042903, "average": 0.861095, "min": 0.470915}, "location": {"width": 111, "top": 1186, "height": 25, "left": 909}, "words": "26-27kDa"}, {"probability": {"variance": 2e-06, "average": 0.998404, "min": 0.997021}, "location": {"width": 54, "top": 1234, "height": 30, "left": 183}, "words": "子量"}, {"probability": {"variance": 0.000664, "average": 0.871859, "min": 0.846092}, "location": {"width": 142, "top": 1264, "height": 27, "left": 651}, "words": " 32OMM Naci"}, {"probability": {"variance": 0.007625, "average": 0.771448, "min": 0.684128}, "location": {"width": 143, "top": 1255, "height": 26, "left": 911}, "words": " 400MM Nacl"}, {"probability": {"variance": 0.025609, "average": 0.93591, "min": 0.512593}, "location": {"width": 296, "top": 1271, "height": 45, "left": 181}, "words": " Source S的洗脱盐浓度"}, {"probability": {"variance": 0.002873, "average": 0.94623, "min": 0.829773}, "location": {"width": 114, "top": 1303, "height": 28, "left": 912}, "words": "肽<10kDa"}, {"probability": {"variance": 0.009408, "average": 0.956039, "min": 0.719255}, "location": {"width": 189, "top": 1325, "height": 36, "left": 183}, "words": "蛋白酶ⅴ8剪切"}, {"probability": {"variance": 0.00622, "average": 0.962467, "min": 0.755359}, "location": {"width": 175, "top": 1309, "height": 30, "left": 652}, "words": "15kDa片段肽"}, {"probability": {"variance": 2e-06, "average": 0.99922, "min": 0.995615}, "location": {"width": 347, "top": 1364, "height": 47, "left": 184}, "words": "抗原5特异性的单克隆抗体"}, {"probability": {"variance": 0.021926, "average": 0.934534, "min": 0.492094}, "location": {"width": 456, "top": 1344, "height": 48, "left": 654}, "words": "可用8E3,1E11检测仪可用8E3检测"}, {"probability": {"variance": 0.004958, "average": 0.97673, "min": 0.699826}, "location": {"width": 531, "top": 1406, "height": 53, "left": 186}, "words": "与过敏反应患者血清的IgE反应频率>95%"}, {"probability": {"variance": 0.00217, "average": 0.96598, "min": 0.885498}, "location": {"width": 57, "top": 1401, "height": 25, "left": 920}, "words": "<10%"}, {"probability": {"variance": 0, "average": 0.999776, "min": 0.999412}, "location": {"width": 116, "top": 1473, "height": 31, "left": 186}, "words": "致敏能力"}, {"probability": {"variance": 0.025678, "average": 0.929753, "min": 0.537323}, "location": {"width": 206, "top": 1453, "height": 36, "left": 657}, "words": "与n抗原5相似"}, {"probability": {"variance": 0.00695, "average": 0.962776, "min": 0.717388}, "location": {"width": 183, "top": 1446, "height": 30, "left": 923}, "words": ">10x小于nAg5"}, {"probability": {"variance": 0, "average": 0.753135, "min": 0.753135}, "location": {"width": 41, "top": 1536, "height": 29, "left": 770}, "words": "L"}], "language": 3}